ID

14786

Descripción

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Patients With Early Stage Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02301988

Link

https://clinicaltrials.gov/show/NCT02301988

Palabras clave

Versiones (1)
  1. 28/4/16 28/4/16 -
Subido en

28 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT02301988

Inglés

Eligibility Breast Cancer NCT02301988

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
premenopausal or postmenopausal women, age >/=18 years
Descripción

Gender | Premenopausal state | Postmenopausal state | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0232969
UMLS CUI [3]
C0232970
UMLS CUI [4]
C0001779
eastern cooperative oncology group (ecog) performance status of 0 or 1
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
histologically documented, stage ia to operable stage iiia, triple-negative carcinoma of the breast with primary tumor >/=1.5 cm in largest diameter (ct1-3) by magnetic resonance imaging (mri)
Descripción

malignant neoplasm of breast staging | Triple-Negative Breast Cancer Finding | primary tumor | Magnetic Resonance Imaging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2216702
UMLS CUI [2]
C2348819
UMLS CUI [3]
C0677930
UMLS CUI [4]
C0024485
adequate hematologic and organ function within 14 days before the first study treatment
Descripción

Hematologic function | body system or organ function | Therapies, Investigational

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0678852
UMLS CUI [3]
C0949266
availability of tumor tissue from formalin-fixed, paraffin-embedded (ffpe) core biopsy of breast primary tumor
Descripción

Tumor tissue sample Formalin-fixed paraffin-embedded tissue specimen Core biopsy of breast primary tumor

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C2711483
UMLS CUI [1,3]
C0842740
UMLS CUI [1,4]
C0677930
for female patients of childbearing potential, agreement to use highly effective form(s) of contraception for the duration of the study and for at least 6 months after last dose of study treatment
Descripción

Gender | Childbearing Potential Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known her2-positive, er-positive, or pgr-positive breast cancer
Descripción

HER2-positive carcinoma of breast | ESTROGEN RECEPTOR (ER) OR PROGESTERONE RECEPTOR (PR) POSITIVE BREAST CANCER

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1960398
UMLS CUI [2]
C1971473
any prior treatment for the current primary invasive breast cancer
Descripción

Prior Therapy Invasive breast carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0853879
patients with ct4 or cn3 stage breast tumors
Descripción

malignant neoplasm of breast staging

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2216702
metastatic (stage iv) breast cancer
Descripción

Carcinoma breast stage IV

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0278488
bilateral invasive breast cancer
Descripción

Invasive breast carcinoma Bilateral

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0238767
multicentric breast cancer
Descripción

Multicentric Breast Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2986664
any disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug or that may affect the interpretation of the results or render the patient at high risk from treatment complications
Descripción

Disease | Metabolic Dysfunction | Physical Examination | Laboratory test finding | Contraindication Investigational New Drugs | Affecting research results | Complications of treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0012634
UMLS CUI [2,1]
C0311400
UMLS CUI [2,2]
C3887504
UMLS CUI [3]
C0031809
UMLS CUI [4]
C0587081
UMLS CUI [5,1]
C0522473
UMLS CUI [5,2]
C0013230
UMLS CUI [6,1]
C0392760
UMLS CUI [6,2]
C0683954
UMLS CUI [7]
C0679861
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT02301988

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Premenopausal state | Postmenopausal state | Age
Item
premenopausal or postmenopausal women, age >/=18 years
boolean
C0079399 (UMLS CUI [1])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
malignant neoplasm of breast staging | Triple-Negative Breast Cancer Finding | primary tumor | Magnetic Resonance Imaging
Item
histologically documented, stage ia to operable stage iiia, triple-negative carcinoma of the breast with primary tumor >/=1.5 cm in largest diameter (ct1-3) by magnetic resonance imaging (mri)
boolean
C2216702 (UMLS CUI [1])
C2348819 (UMLS CUI [2])
C0677930 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
Hematologic function | body system or organ function | Therapies, Investigational
Item
adequate hematologic and organ function within 14 days before the first study treatment
boolean
C0221130 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
C0949266 (UMLS CUI [3])
Tumor tissue sample Formalin-fixed paraffin-embedded tissue specimen Core biopsy of breast primary tumor
Item
availability of tumor tissue from formalin-fixed, paraffin-embedded (ffpe) core biopsy of breast primary tumor
boolean
C0475358 (UMLS CUI [1,1])
C2711483 (UMLS CUI [1,2])
C0842740 (UMLS CUI [1,3])
C0677930 (UMLS CUI [1,4])
Gender | Childbearing Potential Contraceptive methods
Item
for female patients of childbearing potential, agreement to use highly effective form(s) of contraception for the duration of the study and for at least 6 months after last dose of study treatment
boolean
C0079399 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
HER2-positive carcinoma of breast | ESTROGEN RECEPTOR (ER) OR PROGESTERONE RECEPTOR (PR) POSITIVE BREAST CANCER
Item
known her2-positive, er-positive, or pgr-positive breast cancer
boolean
C1960398 (UMLS CUI [1])
C1971473 (UMLS CUI [2])
Prior Therapy Invasive breast carcinoma
Item
any prior treatment for the current primary invasive breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C0853879 (UMLS CUI [1,2])
malignant neoplasm of breast staging
Item
patients with ct4 or cn3 stage breast tumors
boolean
C2216702 (UMLS CUI [1])
Carcinoma breast stage IV
Item
metastatic (stage iv) breast cancer
boolean
C0278488 (UMLS CUI [1])
Invasive breast carcinoma Bilateral
Item
bilateral invasive breast cancer
boolean
C0853879 (UMLS CUI [1,1])
C0238767 (UMLS CUI [1,2])
Multicentric Breast Carcinoma
Item
multicentric breast cancer
boolean
C2986664 (UMLS CUI [1])
Disease | Metabolic Dysfunction | Physical Examination | Laboratory test finding | Contraindication Investigational New Drugs | Affecting research results | Complications of treatment
Item
any disease, metabolic dysfunction, physical examination finding, or clinical laboratory finding that contraindicates the use of an investigational drug or that may affect the interpretation of the results or render the patient at high risk from treatment complications
boolean
C0012634 (UMLS CUI [1])
C0311400 (UMLS CUI [2,1])
C3887504 (UMLS CUI [2,2])
C0031809 (UMLS CUI [3])
C0587081 (UMLS CUI [4])
C0522473 (UMLS CUI [5,1])
C0013230 (UMLS CUI [5,2])
C0392760 (UMLS CUI [6,1])
C0683954 (UMLS CUI [6,2])
C0679861 (UMLS CUI [7])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial